Related Experiment Video
Updated: Aug 15, 2026

07:31
Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs
Published on: May 24, 2016
Summary
This study found that cancer cells from metastases can spread to new sites, including lymph nodes. The metastatic potential of these secondary cancer cells is similar to that of the primary tumor.
Area of Science:
- Oncology
- Cancer Metastasis Research
Background:
- Understanding the behavior of metastatic cancer cells is crucial for effective treatment strategies.
- Investigating secondary metastatic sites provides insights into cancer dissemination patterns.
Observation:
- Nine cases of metastases originating from known metastatic foci were identified during surgery.
- Primary tumors included melanomas, osteosarcomas, synovial sarcoma, lung carcinoma, and rhabdomyosarcoma.
- Secondary metastatic sites included regional lymph nodes, pulmonary hilum, mediastinum, small bowel mesentery, retroperitoneum, and axilla.
Findings:
- The metastatic potential of cells derived from metastases appears comparable to that of cells from the primary tumor.
- Patients were immunocompetent, demonstrating normal immune responses.
Implications:
- These findings suggest that established metastases possess inherent metastatic capabilities similar to primary tumors.
- Further research into the mechanisms of cancer cell spread from secondary sites is warranted.
- This information may inform the development of targeted therapies for advanced cancers.
Related Concept Videos
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

